Cipher Pharmaceuticals (TSE:CPH) Reaches New 12-Month High – Here’s Why

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as C$17.37 and last traded at C$17.24, with a volume of 28602 shares changing hands. The stock had previously closed at C$16.85.

Cipher Pharmaceuticals Stock Performance

The stock has a 50 day simple moving average of C$14.98 and a 200 day simple moving average of C$14.94. The company has a quick ratio of 2.67, a current ratio of 1.12 and a debt-to-equity ratio of 4.36. The company has a market cap of C$433.32 million, a price-to-earnings ratio of 16.27 and a beta of 1.33.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.